12/09/2024 | Press release | Distributed by Public on 12/09/2024 18:52

Trial Update from IMproveMF, an Ongoing, Open Label, Dose Escalation and Expansion, Phase 1/1B Trial to Evaluate the Safety, Pharmacokinetics, and Clinical Activity of the[...]

Please select the service you want to use:

• Newsvine
• Digg
• Delicious
• StumbleUpon
• Technorati
• Buzz
• Favorites
• Google Reader

 Back

 Download the original document